Budget Amount *help |
¥15,730,000 (Direct Cost: ¥12,100,000、Indirect Cost: ¥3,630,000)
Fiscal Year 2019: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2018: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2017: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
|
Outline of Final Research Achievements |
Hepatocellular carcinoma recurrently develops in cirrhotic liver containing a number of regenerative nodules (RNs). To uncover the molecular basis of tumorigenesis in liver cirrhosis, the genetic aberrations in RNs of cirrhotic tissues were determined using next-generation sequencing method. Our findings suggested that a variety of genetic aberrations accmulate in the RNs of cirrhotic liver before the development of clinically and histologically overt HCC, and these aberrations in RNs could provide the basis of tumorigenesis in patients with liver cirrhosis.
|